Current Startup and Venture Capital News as of 3 September 2026: The Autumn IPO Window Opens, Anthropic Prepares for Historic Listing, the Global Venture Market Absorbs a Record $510 Billion in Half-Year Investments, and Capital Continues to Concentrate Around AI Leaders.
The start of September 2026 finds the venture market in a state that seemed impossible just three years ago. Global venture investments for the first half of the year have reached a record $510 billion, surpassing the entire result of 2025. The IPO market is experiencing its best period in a decade, and M&A deals involving tech companies are hitting historic highs. For venture investors and funds, this autumn is crucial: the window for public offerings is open, but the question of how long it will remain so grows ever more pressing.
Key topics on the venture agenda for Thursday, 3 September 2026:
- Autumn IPO Sprint. Following Labour Day in the U.S., a traditional wave of stock market applications begins, and this year promises to be record-breaking.
- Anthropic on the Cusp of Listing. The world’s most valuable venture startup may go public as early as September-October.
- Concentration of AI Capital. A lion's share of venture funding is going to a narrow circle of frontier laboratories.
- Fresh Rounds of the Week. Generative 3D, energy, fintech, and AI infrastructure attract hundreds of millions of dollars.
- Diversification Beyond AI. Defense technologies, robotics, and biotech are increasing their share in fund portfolios.
Autumn IPO Window: Sprint After Labour Day Gains Momentum
The American IPO market is entering its hottest phase of the year. By the end of May, over $34 billion had already been raised through IPOs—a year-on-year increase of over 160%, with the number of public offerings exceeding one hundred. The headliner of 2026 was SpaceX, which conducted the largest IPO in history: the company's shares closed up 19% on the first day of trading. Now, with the onset of September, investor attention shifts to the next wave of candidates.
Analysts warn: the window of opportunity is narrowing, and companies planning to list in 2026 must act quickly. In the coming months, players from the fields of artificial intelligence, fintech, cryptocurrency, consumer health, and climate technologies may go public. Finnish company Oura, which has raised $1.5 billion in venture capital, is considering a listing as early as September-October.
Anthropic Prepares for Historic Listing
The main intrigue of the autumn is the possible debut of Anthropic on the public market. The developer of the Claude model family, which has become the world’s most valuable venture startup with a valuation nearing $1 trillion, has confidentially submitted its IPO documents and, according to business media, may list as early as September or October, raising up to $100 billion. This would make the listing the largest in the history of the tech sector.
Significantly, Anthropic is striving to outpace its main competitor: OpenAI, which closed the largest private round in history this spring for $122 billion at a valuation of $852 billion, is leaning towards postponing its own IPO to 2027. For venture funds, the outcome of this race is crucial—a successful listing by Anthropic could unlock liquidity worth hundreds of billions of dollars and set a price benchmark for the entire AI industry.
Record Half-Year: $510 Billion and Unprecedented Concentration of Capital
The results for the first half of 2026 confirm that the venture market is undergoing not just a recovery, but a structural transformation. Key numbers are as follows:
- Global venture investments reached $510 billion in the half-year—more than the entire year of 2025 ($440 billion).
- North America attracted $392 billion, setting an absolute record.
- OpenAI and Anthropic accounted for $217 billion—43% of all global venture funding.
- In the second quarter, 16 companies closed rounds exceeding $1 billion, totaling $108.6 billion.
Seven out of the sixteen billion-dollar rounds went to frontier AI laboratories, including China's DeepSeek, StepFun, and Moonshot AI, the UK's Ineffable Intelligence, and America's Prometheus and Isomorphic Labs. Capital is concentrating in the hands of a few—and this is the primary structural risk of the current cycle, which venture investors must consider when building their portfolios.
Early Stages Revive: Mega Rounds Enter Seed and Series A
Contrary to fears that the AI boom would drain resources from early stages, investments in young startups in North America reached $31 billion for the quarter—a maximum in over three years. The phenomenon of the quarter is a $12 billion round for Prometheus, a physical AI startup co-founded by Jeff Bezos. Following closely are Hark with a $700 million round for "personalized intelligence" and Flourish, creating an AI system modeled after the human brain.
Meanwhile, the number of deals in early stages has dropped to a five-quarter low—the market is paying more but selecting more rigorously. For early-stage funds, this means increased competition for truly high-quality projects.
Deals of the Week: From Generative 3D to Energy Networks
The beginning of September has brought a series of illustrative rounds reflecting the current priorities of venture capital:
- Tripo AI / VAST—approximately $446 million (3 billion yuan) in Series B and B+ rounds for the development of generative 3D models, with participation from CICC, CMC Capital Partners, and Primavera Capital.
- Félix—$200 million Series C for a Miami-based fintech platform with a substantial debt component in the deal structure.
- Gridsight—$26 million Series B led by Insight Partners for an AI platform for managing power grid capacity.
- Wispr AI—$280 million Series B at a valuation of $2 billion.
- Sila—$300 million for advanced battery technologies from Atreides Management and Sutter Hill Ventures.
Special attention is warranted for AI infrastructure: Baseten closed a Series F round of $1.5 billion at a valuation of $13 billion—the fourth round for the company in a year and a half amid a twenty-fold increase in revenue.
Diversification: Defense, Robotics, and Biotech Gain Weight
Although artificial intelligence remains the gravitational center of the market, venture investments are increasingly spreading to adjacent sectors. Defense technologies attracted $12.3 billion in the first half of the year—almost double what they raised the previous year. Investments in humanoid robotics startups have reached historical highs. Biotech consistently ranks among the top three sectors for weekly rounds, while the energy sector marked strategic financing of $1.75 billion for Joulent.
Fund consolidation continues: Khosla Ventures is negotiating to raise up to $5.5 billion in a new line of funds, while Abu Dhabi’s sovereign fund MGX has closed its first fund at $49 billion, surpassing its target.
M&A and Exits: Consolidation as a Strategy
The second quarter became one of the strongest periods for venture exits in years. A landmark deal remains SpaceX’s acquisition of startup Cursor—the largest acquisition of a venture-backed company in history. Pharma giant Eli Lilly acquired biotech Kelonia in the largest venture startup deal in years. For funds, this signals that strategic buyers have returned to the market, and the prospect of selling to a corporation has once again become a viable alternative to an IPO.
Russia and CIS: The Market Seeks a New Growth Model
The Russian venture market is moving against the global trend: its annual volume has decreased by about 10% to 7.2 billion rubles, while corporate venture investments have fallen by four times. However, there are growth points within the decline: investments from private funds have increased by 69% to 2.9 billion rubles, and the first half of the year showed a market growth of 70% following several years of decline. New structures are being launched—Kama Flow and “Medscan” funds at 10 billion rubles each, as well as a specialized fund for startups based on AI agents. Market participants are pinning hopes on a reduction in the key interest rate and possible IPOs in 2026.
Outlook: Autumn Will Define the Cycle's Resilience
September 2026 will test the resilience of the entire venture cycle. Successful listings by Anthropic, Oura, and other candidates could solidify the boom and restore liquidity to the ecosystem. A failure or postponement of key IPOs, on the other hand, would intensify discussions about overheating—the signs of cooling in the megaround market are already being recorded, and consolidation in applied AI verticals is accelerating. Venture investors should maintain discipline: diversify portfolios beyond frontier laboratories, allocate increased early-stage capital reserves for portfolio companies, and prepare them for scenarios of strategic exits. The market is as generous as ever—but it is precisely at such moments that the cost of mistakes is at its highest.
